CH515231A - Verfahren zur Herstellung von heterocyclischen Essigsäurederivaten - Google Patents

Verfahren zur Herstellung von heterocyclischen Essigsäurederivaten

Info

Publication number
CH515231A
CH515231A CH568269A CH568269A CH515231A CH 515231 A CH515231 A CH 515231A CH 568269 A CH568269 A CH 568269A CH 568269 A CH568269 A CH 568269A CH 515231 A CH515231 A CH 515231A
Authority
CH
Switzerland
Prior art keywords
preparation
acetic acid
acid derivatives
heterocyclic acetic
heterocyclic
Prior art date
Application number
CH568269A
Other languages
German (de)
English (en)
Inventor
Michael O'mant Derrick
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Priority to CH1351371A priority Critical patent/CH518276A/de
Priority to CH1351271A priority patent/CH518275A/de
Priority to CH1351471A priority patent/CH518277A/de
Publication of CH515231A publication Critical patent/CH515231A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/42—Singly bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28—Halogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
CH568269A 1968-04-16 1969-04-15 Verfahren zur Herstellung von heterocyclischen Essigsäurederivaten CH515231A (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CH1351371A CH518276A (de) 1968-10-25 1969-04-15 Verfahren zur Herstellung von heterocyclischen Verbindungen
CH1351271A CH518275A (de) 1968-10-25 1969-04-15 Verfahren zur Herstellung von heterocyclischen Verbindungen
CH1351471A CH518277A (de) 1968-12-10 1969-04-15 Verfahren zur Herstellung von heterocyclischen Verbindungen

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1789568 1968-04-16
GB5078868 1968-10-25
GB5866668 1968-12-10

Publications (1)

Publication Number Publication Date
CH515231A true CH515231A (de) 1971-11-15

Family

ID=27257551

Family Applications (1)

Application Number Title Priority Date Filing Date
CH568269A CH515231A (de) 1968-04-16 1969-04-15 Verfahren zur Herstellung von heterocyclischen Essigsäurederivaten

Country Status (9)

Country Link
JP (1) JPS4913789B1 (he)
BE (1) BE731549A (he)
CH (1) CH515231A (he)
DE (1) DE1919381B2 (he)
FR (1) FR2007466A1 (he)
IE (1) IE33054B1 (he)
IL (1) IL31991A (he)
NL (1) NL6905846A (he)
SE (1) SE366038B (he)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1377248A (en) * 1972-04-25 1974-12-11 Ici Ltd Furan derivatives
FR2421897A1 (fr) * 1978-04-04 1979-11-02 Labaz Nouveaux derives du thiophene, leur procede de preparation ainsi que les compositions therapeutiques les contenant
FR2537138A1 (fr) * 1982-12-03 1984-06-08 Roussel Uclaf Procede de preparation de derives de l'acide 2-thiophene acetique
FR2537137B1 (fr) * 1982-12-03 1985-07-19 Roussel Uclaf Procede de preparation de derives de l'acide 2-thiophene acetique et produits intermediaires necessaires pour leur preparation
FR2578253B1 (fr) * 1985-03-01 1987-05-22 Roussel Uclaf Nouveaux produits derives de l'acide thienyl 2-malonique, leur procede de preparation et leur application
ZA918719B (en) * 1990-11-07 1992-08-26 Cortech Inc Ester inhibitors
US5240956A (en) * 1990-11-07 1993-08-31 Cortech, Inc. Ester inhibitors
AU2936295A (en) * 1994-07-13 1996-02-16 Taisho Pharmaceutical Co., Ltd. Thiopheneacetic acid derivative
CA3073810A1 (en) * 2017-08-31 2019-03-07 Ahammune Biosciences Private Limited Thiophene-derived compounds, process for synthesis and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3449368A (en) * 1964-12-30 1969-06-10 Merck & Co Inc Heterocyclic aliphatic acids
GB1139164A (en) * 1966-12-05 1969-01-08 Parke Davis & Co New heterocyclic acetic acid compounds and methods for their production

Also Published As

Publication number Publication date
DE1919381C3 (he) 1975-02-06
NL6905846A (he) 1969-10-20
SE366038B (he) 1974-04-08
DE1919381B2 (de) 1974-05-16
BE731549A (he) 1969-10-15
IE33054B1 (en) 1974-03-06
DE1919381A1 (de) 1969-10-23
IL31991A0 (en) 1969-06-25
IL31991A (he) 1971-12-29
IE33054L (en) 1969-10-16
JPS4913789B1 (he) 1974-04-03
FR2007466A1 (en) 1970-01-09

Similar Documents

Publication Publication Date Title
CH513786A (de) Verfahren zur Herstellung von Styrylnaphthalin-Derivaten
CH513856A (de) Verfahren zur Herstellung von Piperidinderivaten
CH520160A (de) Verfahren zur Herstellung von Thioninderivaten
CH529134A (de) Verfahren zur Herstellung von Pyridoxin-a-ketoglutarat-Derivaten
CH527216A (de) Verfahren zur Herstellung von 3-Cephemderivaten
CH515231A (de) Verfahren zur Herstellung von heterocyclischen Essigsäurederivaten
AT293432B (de) Verfahren zur Herstellung von neuen Dithiocarbazinsäureester-Derivaten
CH544773A (de) Verfahren zur Herstellung von Cephalosporansäure-Derivaten
CH532581A (de) Verfahren zur Herstellung von 14-Hydroxynormorphinonderivaten
CH512421A (de) Verfahren zur Herstellung von Essigsäureestern
AT319482B (de) Verfahren zur Herstellung von Chinolinderivaten
CH529132A (de) Verfahren zur Herstellung von 3-Indolylacetamidderivaten
CH504473A (de) Verfahren zur Herstellung von Cephalosporansäurederivaten
CH500222A (de) Verfahren zur Herstellung von Penicilloinsäurederivaten
AT319481B (de) Verfahren zur Herstellung von Chinolinderivaten
CH519458A (de) Verfahren zur Herstellung von Isoprenoidchinonderivaten
CH518956A (de) Verfahren zur Herstellung von Isochinuclidin-Derivaten
CH513863A (de) Verfahren zur Herstellung von Benzomorphanderivaten
AT294798B (de) Verfahren zur Herstellung von Formamidinderivaten
CH521949A (de) Verfahren zur Herstellung von Formamido-cycloalkanderivaten
CH522676A (de) Verfahren zur Herstellung von 5-Nitrofuranderivaten
CH510682A (de) Verfahren zur Herstellung von Dihalogentriazinderivaten
CH517112A (de) Verfahren zur Herstellung von N-Glykoluril-Derivaten
CH529135A (de) Verfahren zur Herstellung von Cycloalkanochinolonderivaten
AT309676B (de) Verfahren zur Herstellung von 7-Aminocephalosporansäure-Derivaten

Legal Events

Date Code Title Description
PL Patent ceased